Victoria Williams

Victoria Williams

Auto-generated profile, based on publicly available information

Victoria Williams

University of Bristol

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Health Services and Delivery Research
Verified
Journal Article
Closed access
PDF file
APAlison Porter
Alison Porter
ABAnisha Badshah
Anisha Badshah
SBSarah Black
Sarah Black
DFDavid Fitzpatrick
David Fitzpatrick
RHRobert Harris-Mayes
Robert Harris-Mayes
VWVictoria Williams
Victoria Williams
Background: Ambulance services have a vital role in the shift towards the delivery of health care outside hospitals, when this is better for patients, by offering alternatives to transfer to the emergency department. The introduction of information technology in ambulance services to electronically capture, interpret, store and transfer patient data can support out-of-hospital care. Objective: We aimed to understand how electronic health records can be most effectively implemented in a pre-hospital context in order to support a safe and effective shift from acute to community-based care, and how their potential benefits can be maximised. Design and setting: We carried out a study using multiple methods and with four work packages: (1) a rapid literature review; (2) a telephone survey of all 13 freestanding UK ambulance services; (3) detailed case studies examining electronic health record use through qualitative methods and analysis of routine data in four selected sites consisting of UK ambulance services and their associated health economies; and (4) a knowledge-sharing workshop. Results: We found limited literature on electronic health records. Only half of the UK ambulance services had electronic health records in use at the time of data collection, with considerable variation in hardware and software and some reversion to use of paper records as services transitioned between systems. The case studies found that the ambulance services’ electronic health records were in a state of change. Not all patient contacts resulted in the generation of electronic health records. Ambulance clinicians were dealing with partial or unclear information, which may not fit comfortably with the electronic health records. Ambulance clinicians continued to use indirect data input approaches (such as first writing on a glove) even when using electronic health records. The primary function of electronic health records in all services seemed to be as a store for patient data. There was, as yet, limited evidence of electronic health records’ full potential being realised to transfer information, support decision-making or change patient care. Limitations: Limitations included the difficulty of obtaining sets of matching routine data for analysis, difficulties of attributing any change in practice to electronic health records within a complex system and the rapidly changing environment, which means that some of our observations may no longer reflect reality. Conclusions: Realising all the benefits of electronic health records requires engagement with other parts of the local health economy and dealing with variations between providers and the challenges of interoperability. Clinicians and data managers, and those working in different parts of the health economy, are likely to want very different things from a data set and need to be presented with only the information that they need. Future work: There is scope for future work analysing ambulance service routine data sets, qualitative work to examine transfer of information at the emergency department and patients’ perspectives on record-keeping, and to develop and evaluate feedback to clinicians based on patient records. Study registration: This study is registered as Health and Care Research Wales Clinical Research Portfolio 34166. Funding: This project was funded by the National Institute for Health Research (NIHR) Health Services and Delivery Research programme and will be published in full in Health Services and Delivery Research; Vol. 8, No. 10. See the NIHR Journals Library website for further project information.

20 May 2025 in Public Health
Verified
Journal Article
Open access
HSH.A. Snooks
H.A. Snooks
AAA. Akbari
A. Akbari
LBL. Bethell
L. Bethell
ACA. Carson-Stevens
A. Carson-Stevens
JDJ. Dale
J. Dale
VWV. Williams
V. Williams
To assess outcomes associated with shielding, introduced during the COVID-19 pandemic across the UK to protect those at highest risk of harm. Linked data and questionnaires in matched cohorts from the population of Wales, UK. We compared individual-level linked routine and self-reported outcomes between people identified for shielding (n = 123,293) and comparators (n = 120,997) matched by age, sex, and previous health service utilisation. We sent questionnaires to 1500 randomly sampled people in each cohort. At one year 6·1 % of shielded people had contracted SARS-CoV-2 compared to 6·2 % in the matched cohort (Adjusted Odds Ratio [AOR] 0·970; 95 % confidence interval [CI] 0·937 to 1·004). Suspected healthcare associated infections were more likely in shielded people (1·1 % vs 0·6 %; AOR 1·678; 95 % CI 1·529 to 1·842). All-cause and COVID-19 related deaths were higher in the shielded cohort (7·0 % vs 3·5 %; AOR 2·280; 95 % CI 2·190 to 2·374; and 1·1 % vs 0·8 %; AOR 1·430; 95 % CI 1·308 to 1·563, respectively). About 1/3 completed questionnaires (n = 1015), with linkage possible in 752 cases (shielded: n = 411; matched: n = 341). Shielded respondents reported lower physical and mental health (SF12 PCS difference: -3·752; 95 % CI -4·823 to -2·682; SF12 MCS difference: -1·217; 95 % CI -2·580 to 0·145). They were more likely to have strictly avoided contact; stayed at home; felt scared to go outside; and were less likely to have gone out for shopping, leisure or travel. We found no evidence of a protective effect of shielding on SARS-CoV-2 infections or COVID-19 related mortality, an increased rate of hospital acquired infections and increased self-isolation. Shielding during a future pandemic should only be considered alongside effective measures to reduce healthcare associated infections.

26 November 2023 in BMC Public Health
Verified
Journal Article
Open access
PDF file
BSBernadette Sewell
Bernadette Sewell
AFAngela Farr
Angela Farr
AAAshley Akbari
Ashley Akbari
ACAndrew Carson-Stevens
Andrew Carson-Stevens
JDJeremy Dale
Jeremy Dale
HSHelen Snooks
Helen Snooks
Background: The EVITE Immunity study investigated the effects of shielding Clinically Extremely Vulnerable (CEV) people during the COVID-19 pandemic on health outcomes and healthcare costs in Wales, United Kingdom, to help prepare for future pandemics. Shielding was intended to protect those at highest risk of serious harm from COVID-19. We report the cost of implementing shielding in Wales. Methods: The number of people shielding was extracted from the Secure Anonymised Information Linkage Databank. Resources supporting shielding between March and June 2020 were mapped using published reports, web pages, freedom of information requests to Welsh Government and personal communications (e.g. with the office of the Chief Medical Officer for Wales). Results: At the beginning of shielding, 117,415 people were on the shielding list. The total additional cost to support those advised to stay home during the initial 14 weeks of the pandemic was £13,307,654 (£113 per person shielded). This included the new resources required to compile the shielding list, inform CEV people of the shielding intervention and provide medicine and food deliveries. The list was adjusted weekly over the 3-month period (130,000 people identified by June 2020). Therefore the cost per person shielded lies between £102 and £113 per person. Conclusion: This is the first evaluation of the cost of the measures put in place to support those identified to shield in Wales. However, no data on opportunity cost was available. The true costs of shielding including its budget impact and opportunity costs need to be investigated to decide whether shielding is a worthwhile policy for future health emergencies.

24 February 2026 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
VWVictoria Williams
Victoria Williams
SRSophie Rees
Sophie Rees
HSHolly Seale
Holly Seale
GTGrace Tilzey
Grace Tilzey
RLRajeka Lazarus
Rajeka Lazarus
Vaccine co-administration is common in childhood immunization programmes and helps facilitate the uptake of and adherence to the immunization schedule. There are limited data on the role of co-administration in the adult vaccine schedule and attitudes toward this approach. We aimed to understand the experiences and perceptions of vaccine co-administration of trial participants and study staff members. The study was an integrated qualitative study that formed part of ZosterFluCov, a randomized controlled trial which assessed the immunogenicity of seasonal influenza and COVID-19 vaccines when given with a recombinant zoster vaccine (shingles vaccine). Using semi-structured interviews, we explored the perceptions and experiences of participants and study staff members around vaccine co-administration, and concerns and information needs. We interviewed 20 trial participants and 24 research delivery staff. We found that the co-administration of routine vaccines was highly acceptable amongst the trial participants. Staff viewed vaccine co-administration as within their scope of practice and many had experience of it prior to the trial. Participants from both groups felt that vaccine co-administration could be a time efficient way to administer vaccines, for both health professionals and patients. Vaccine co-administration was regarded as an acceptable method of delivery with the potential to save resources whilst simplifying the process for individuals. The importance of personal preference regarding the number of vaccines was emphasized, whilst staff noted that practical adjustments would be needed for real world delivery. Vaccination co-administration offers the opportunity to optimize vaccine coverage amongst those eligible for routine and seasonal vaccinations.

4 December 2021 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
VWVictoria R Williams
Victoria R Williams
MMMatthew Muller
Matthew Muller
JPJeff Powis
Jeff Powis
DRDaniel R Ricciuto
Daniel R Ricciuto
DMDominik Mertz
Dominik Mertz
JLJerome A Leis
Jerome A Leis
Hand hygiene (HH) is a standard infection prevention and control precaution to be applied in healthcare settings to prevent transmission of COVID-19. Many healthcare institutions observed significant improvements in HH performance during wave one of the COVID-19 pandemic but the sustainability of this change is unknown. Our aim was to evaluate long-term HH performance throughout subsequent waves of the pandemic across acute care hospitals in Ontario, Canada. HH adherence was measured using a previously validated group electronic monitoring system which was installed on all alcohol handrub and sink soap dispensers inside and outside each patient room across 56 inpatient units (35 wards and 21 critical care units) spanning 13 acute care hospitals (6 university and 7 community teaching hospitals) from 1 November 2019 to 31 May 2021. Daily HH adherence was compared with daily COVID-19 case count across Ontario. During this period, weekly performance continued to be reported to units but unit-based quality improvement discussions were inconsistent due to the COVID-19 response. Figure 1 depicts daily aggregate HH adherence plotted against the new daily COVID-19 case count across Ontario. An elevation in HH adherence was seen prior to the start of the first wave, rising almost to 80% and then remained above 70% for the peak of wave one. During waves two and three, peak COVID-19 case counts were associated with a maximum HH adherence of 51%, only marginally above the pre-pandemic baseline. After the end of wave one (from 1 July 2020 to 31 May 2021) the median HH performance was only 49% (interquartile range 47%-50%). Figure 1. Hand hygiene adherence across 13 acute care hospitals in comparison to overall new daily COVID-19 cases in Ontario Initial improvements in HH adherence preceding the start of the COVID-19 pandemic were not sustained, possibly due to increasing comfort and reduced anxiety associated with providing care to COVID-19 patients leading to a perception of reduced COVID-19 transmission risk. These findings highlight the need for HH monitoring to be tied to longitudinal unit-led quality improvement in order to achieve durable changes in practice. Susy S. Hota, MSc MD FRCPC, Finch Therapeutics (Research Grant or Support) Susy S. Hota, MSc MD FRCPC, Finch Therapeutics (Individual(s) Involved: Self): Grant/Research Support